<p>Maia Wealth LLC 在最近向证券交易委员会提交的 13F 文件中披露，其在礼来公司（NYSE:LLY - 免费报告）的持股在第一季度增加了 22.3%。该机构投资者在本季度额外购买了 565 股后，持有该公司 3,093 股股票。截至其最近的 SEC 文件，Maia Wealth LLC 在礼来公司的持股价值为 2,334,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>特朗普 GLP-1 试点计划可能会推动诺和诺德和礼来</li>
</ul>
<p>其他几家机构投资者也增加或减少了对该股票的持股。PNC 金融服务集团在第一季度将其在礼来公司的持股提高了 97.5%。PNC 金融服务集团现在拥有 101,305,650 股该公司的股票，价值 83,669,349,000 美元，此前在上个季度额外购买了 50,002,551 股。先锋集团在第一季度将其在礼来公司的持股提高了 6.7%。先锋集团现在拥有 79,224,392 股该公司的股票，价值 65,432,218,000 美元，此前在上个季度额外购买了 4,975,395 股。GAMMA 投资公司在第一季度将其在礼来公司的持股提高了 103,831.6%。GAMMA 投资公司现在拥有 14,866,380 股该公司的股票，价值 12,278,292,000 美元，此前在上个季度额外购买了 14,852,076 股。资本研究全球投资者在第四季度将其在礼来公司的持股提高了 16.1%。资本研究全球投资者现在拥有 10,757,511 股该公司的股票，价值 8,304,811,000 美元，此前在上个季度额外购买了 1,493,673 股。最后，北方信托公司在第四季度将其在礼来公司的持股提高了 14.6%。北方信托公司现在拥有 9,448,219 股该公司的股票，价值 7,294,025,000 美元，此前在上个季度额外购买了 1,204,337 股。82.53% 的股票由机构投资者持有。</p>
<h2>分析师评级变动</h2>
<p>几位股票研究分析师最近对 LLY 股票发表了评论。古根海姆在 7 月 11 日的研究报告中将礼来公司的股票目标价从 936.00 美元上调至 942.00 美元，并给予该公司 “买入” 评级。Leerink Partners 在周四的研究报告中重申了 “市场表现” 评级，并设定了 715.00 美元的目标价。Cantor Fitzgerald 在 4 月 22 日的研究报告中开始覆盖礼来公司的股票。他们设定了 “增持” 评级和 975.00 美元的目标价。瑞银集团在周五的研究报告中将礼来公司的股票目标价从 1,050.00 美元下调至 895.00 美元，并对该股票设定了 “买入” 评级。最后，汇丰银行在 4 月 28 日的研究报告中将礼来公司的股票评级从 “买入” 下调至 “减持”，并将该股票的目标价从 1,150.00 美元下调至 700.00 美元。一位分析师对该股票给予了卖出评级，五位分析师给予了持有评级，十六位分析师对该公司的股票给予了买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 984.41 美元。</p>
<ul>
<li>礼来公司 14% 的财报后下滑是否是买入机会？</li>
</ul>
<p><strong>阅读我们最新的 LLY 股票分析</strong></p>
<h2>礼来公司股票表现</h2>
<p>NYSE LLY 周一开盘价为 625.15 美元。该股票的市值为 5916.8 亿美元，市盈率为 40.86，市盈增长比率为 0.87，贝塔值为 0.44。该公司的债务与股本比率为 1.86，速动比率为 1.00，流动比率为 1.28。该公司的 50 日移动平均线为 774.10 美元，200 日移动平均线为 799.34 美元。礼来公司的 52 周低点为 623.78 美元，52 周高点为 972.53 美元。</p>
<ul>
<li>诺和诺德股票下跌——但底部终于到了吗？</li>
</ul>
<p>礼来公司（NYSE:LLY - 获取免费报告）最近在 8 月 7 日发布了季度财报。该公司报告本季度每股收益为 6.31 美元，超出市场共识预期的 5.59 美元，超出 0.72 美元。该公司本季度的收入为 155.6 亿美元，而分析师预期为 144 亿美元。礼来公司的净利润率为 25.91%，股本回报率为 92.72%。该公司的收入同比增长 37.6%。在去年同期，该公司每股收益为 3.92 美元。平均而言，卖方分析师预计礼来公司今年将发布 23.48 美元的每股收益。</p>
<h2>礼来公司分红公告</h2>
<p>该公司最近还宣布了一项季度分红，将于 9 月 10 日（星期三）支付。8 月 15 日（星期五）的股东将获得 1.50 美元的分红。这代表着每年 6.00 美元的分红和 1.0% 的收益率。该分红的除息日为 8 月 15 日（星期五）。礼来公司的分红支付比率目前为 48.82%。</p>
<h2>内部人士下注</h2>
<p>在相关消息中，董事 Jamere Jackson 在 8 月 8 日（星期五）以 639.56 美元的平均成本购买了 200 股该股票，总价值为 127,912.00 美元。收购后，该董事直接持有该公司 9,402 股，价值为 6,013,143.12 美元。此次交易使其持股增加了 2.17%。该收购已在向 SEC 提交的文件中披露，文件可通过此链接访问。0.14% 的股票目前由公司内部人士持有。</p>
<h2>礼来公司公司简介</h2>
<p>（免费报告）</p>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供用于糖尿病的 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素 lispro、胰岛素 lispro 原料、胰岛素 lispro 混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500；用于 2 型糖尿病的 Jardiance、Mounjaro 和 Trulicity；以及用于肥胖症的 Zepbound。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>如何投资蓝筹股</li>
<li>3 只提高分红的股票——并以业绩支持这一点</li>
<li>投资者最重要的沃伦·巴菲特股票：他自己的股票</li>
<li>3 只拥有垄断权力且竞争极少的股票</li>
<li>成长投资：你应该在 2022 年采用这种投资策略吗？</li>
<li>火箭实验室发布第二季度业绩：牛市论点仍然成立吗？</li>
</ul>
<p><strong>想看看其他对 LLY 感兴趣的对冲基金持有什么吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在你考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>Maia Wealth LLC 在第一季度将其在礼来公司（NYSE: LLY）的持股增加了 22.3%，增持了 565 股，总持股达到 3,093 股，市值为 233 万美元。其他机构投资者也显著增加了他们的持股。分析师对礼来的评级显示出买入和持有评级的混合，平均目标价为 984.41 美元。该股票开盘价为 625.15 美元，市值为 5916.8 亿美元，最近的财报显示出强劲的表现，EPS 为 6.31 美元，超出预期</p>

<p>Maia Wealth LLC boosted its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 22.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,093 shares of the company's stock after acquiring an additional 565 shares during the quarter. Maia Wealth LLC's holdings in Eli Lilly and Company were worth $2,334,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Maia Wealth LLC 在最近向证券交易委员会提交的 13F 文件中披露，其在礼来公司（NYSE:LLY - 免费报告）的持股在第一季度增加了 22.3%。该机构投资者在本季度额外购买了 565 股后，持有该公司 3,093 股股票。截至其最近的 SEC 文件，Maia Wealth LLC 在礼来公司的持股价值为 2,334,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>Trump GLP-1 Pilot Program Could Boost Novo Nordisk &amp; Eli Lilly</li>
</ul>
<div class="lb-trans"><ul>
<li>特朗普 GLP-1 试点计划可能会推动诺和诺德和礼来</li>
</ul>
</div><p>Several other institutional investors have also added to or reduced their stakes in the stock. PNC Financial Services Group Inc. lifted its position in Eli Lilly and Company by 97.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 101,305,650 shares of the company's stock valued at $83,669,349,000 after acquiring an additional 50,002,551 shares in the last quarter. Vanguard Group Inc. lifted its position in Eli Lilly and Company by 6.7% in the 1st quarter. Vanguard Group Inc. now owns 79,224,392 shares of the company's stock valued at $65,432,218,000 after acquiring an additional 4,975,395 shares in the last quarter. GAMMA Investing LLC lifted its position in Eli Lilly and Company by 103,831.6% in the 1st quarter. GAMMA Investing LLC now owns 14,866,380 shares of the company's stock valued at $12,278,292,000 after acquiring an additional 14,852,076 shares in the last quarter. Capital Research Global Investors lifted its position in Eli Lilly and Company by 16.1% in the 4th quarter. Capital Research Global Investors now owns 10,757,511 shares of the company's stock valued at $8,304,811,000 after acquiring an additional 1,493,673 shares in the last quarter. Finally, Northern Trust Corp lifted its position in Eli Lilly and Company by 14.6% in the 4th quarter. Northern Trust Corp now owns 9,448,219 shares of the company's stock valued at $7,294,025,000 after acquiring an additional 1,204,337 shares in the last quarter. 82.53% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他几家机构投资者也增加或减少了对该股票的持股。PNC 金融服务集团在第一季度将其在礼来公司的持股提高了 97.5%。PNC 金融服务集团现在拥有 101,305,650 股该公司的股票，价值 83,669,349,000 美元，此前在上个季度额外购买了 50,002,551 股。先锋集团在第一季度将其在礼来公司的持股提高了 6.7%。先锋集团现在拥有 79,224,392 股该公司的股票，价值 65,432,218,000 美元，此前在上个季度额外购买了 4,975,395 股。GAMMA 投资公司在第一季度将其在礼来公司的持股提高了 103,831.6%。GAMMA 投资公司现在拥有 14,866,380 股该公司的股票，价值 12,278,292,000 美元，此前在上个季度额外购买了 14,852,076 股。资本研究全球投资者在第四季度将其在礼来公司的持股提高了 16.1%。资本研究全球投资者现在拥有 10,757,511 股该公司的股票，价值 8,304,811,000 美元，此前在上个季度额外购买了 1,493,673 股。最后，北方信托公司在第四季度将其在礼来公司的持股提高了 14.6%。北方信托公司现在拥有 9,448,219 股该公司的股票，价值 7,294,025,000 美元，此前在上个季度额外购买了 1,204,337 股。82.53% 的股票由机构投资者持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several equities research analysts recently commented on LLY shares. Guggenheim boosted their price objective on shares of Eli Lilly and Company from $936.00 to $942.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, July 11th. Leerink Partners reissued a &#34;market perform&#34; rating and set a $715.00 price target on shares of Eli Lilly and Company in a research report on Thursday. Cantor Fitzgerald assumed coverage on shares of Eli Lilly and Company in a research report on Tuesday, April 22nd. They set an &#34;overweight&#34; rating and a $975.00 price target on the stock. UBS Group cut their price target on shares of Eli Lilly and Company from $1,050.00 to $895.00 and set a &#34;buy&#34; rating on the stock in a research report on Friday. Finally, HSBC cut shares of Eli Lilly and Company from a &#34;buy&#34; rating to a &#34;reduce&#34; rating and cut their price target for the stock from $1,150.00 to $700.00 in a research report on Monday, April 28th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $984.41.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 LLY 股票发表了评论。古根海姆在 7 月 11 日的研究报告中将礼来公司的股票目标价从 936.00 美元上调至 942.00 美元，并给予该公司 “买入” 评级。Leerink Partners 在周四的研究报告中重申了 “市场表现” 评级，并设定了 715.00 美元的目标价。Cantor Fitzgerald 在 4 月 22 日的研究报告中开始覆盖礼来公司的股票。他们设定了 “增持” 评级和 975.00 美元的目标价。瑞银集团在周五的研究报告中将礼来公司的股票目标价从 1,050.00 美元下调至 895.00 美元，并对该股票设定了 “买入” 评级。最后，汇丰银行在 4 月 28 日的研究报告中将礼来公司的股票评级从 “买入” 下调至 “减持”，并将该股票的目标价从 1,150.00 美元下调至 700.00 美元。一位分析师对该股票给予了卖出评级，五位分析师给予了持有评级，十六位分析师对该公司的股票给予了买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 984.41 美元。</p>
</div><ul>
<li>Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?</li>
</ul>
<div class="lb-trans"><ul>
<li>礼来公司 14% 的财报后下滑是否是买入机会？</li>
</ul>
</div><p><strong>Read Our Latest Stock Analysis on LLY</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 LLY 股票分析</strong></p>
</div><h2>Eli Lilly and Company Stock Performance</h2>
<div class="lb-trans"><h2>礼来公司股票表现</h2>
</div><p>NYSE LLY opened at $625.15 on Monday. The stock has a market cap of $591.68 billion, a PE ratio of 40.86, a P/E/G ratio of 0.87 and a beta of 0.44. The company has a debt-to-equity ratio of 1.86, a quick ratio of 1.00 and a current ratio of 1.28. The firm has a 50-day moving average of $774.10 and a 200-day moving average of $799.34. Eli Lilly and Company has a 52-week low of $623.78 and a 52-week high of $972.53.</p>
<div class="lb-trans"><p>NYSE LLY 周一开盘价为 625.15 美元。该股票的市值为 5916.8 亿美元，市盈率为 40.86，市盈增长比率为 0.87，贝塔值为 0.44。该公司的债务与股本比率为 1.86，速动比率为 1.00，流动比率为 1.28。该公司的 50 日移动平均线为 774.10 美元，200 日移动平均线为 799.34 美元。礼来公司的 52 周低点为 623.78 美元，52 周高点为 972.53 美元。</p>
</div><ul>
<li>Novo Nordisk Stock Sinks—But Is a Bottom Finally In?</li>
</ul>
<div class="lb-trans"><ul>
<li>诺和诺德股票下跌——但底部终于到了吗？</li>
</ul>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $6.31 earnings per share for the quarter, beating the consensus estimate of $5.59 by $0.72. The firm had revenue of $15.56 billion for the quarter, compared to analysts' expectations of $14.40 billion. Eli Lilly and Company had a net margin of 25.91% and a return on equity of 92.72%. The business's revenue was up 37.6% on a year-over-year basis. During the same period in the prior year, the firm earned $3.92 EPS. On average, sell-side analysts anticipate that Eli Lilly and Company will post 23.48 EPS for the current year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最近在 8 月 7 日发布了季度财报。该公司报告本季度每股收益为 6.31 美元，超出市场共识预期的 5.59 美元，超出 0.72 美元。该公司本季度的收入为 155.6 亿美元，而分析师预期为 144 亿美元。礼来公司的净利润率为 25.91%，股本回报率为 92.72%。该公司的收入同比增长 37.6%。在去年同期，该公司每股收益为 3.92 美元。平均而言，卖方分析师预计礼来公司今年将发布 23.48 美元的每股收益。</p>
</div><h2>Eli Lilly and Company Dividend Announcement</h2>
<div class="lb-trans"><h2>礼来公司分红公告</h2>
</div><p>The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 10th. Shareholders of record on Friday, August 15th will be issued a $1.50 dividend. This represents a $6.00 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, August 15th. Eli Lilly and Company's dividend payout ratio is currently 48.82%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 9 月 10 日（星期三）支付。8 月 15 日（星期五）的股东将获得 1.50 美元的分红。这代表着每年 6.00 美元的分红和 1.0% 的收益率。该分红的除息日为 8 月 15 日（星期五）。礼来公司的分红支付比率目前为 48.82%。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In related news, Director Jamere Jackson purchased 200 shares of the stock in a transaction on Friday, August 8th. The shares were purchased at an average cost of $639.56 per share, with a total value of $127,912.00. Following the acquisition, the director directly owned 9,402 shares in the company, valued at $6,013,143.12. The trade was a 2.17% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.14% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，董事 Jamere Jackson 在 8 月 8 日（星期五）以 639.56 美元的平均成本购买了 200 股该股票，总价值为 127,912.00 美元。收购后，该董事直接持有该公司 9,402 股，价值为 6,013,143.12 美元。此次交易使其持股增加了 2.17%。该收购已在向 SEC 提交的文件中披露，文件可通过此链接访问。0.14% 的股票目前由公司内部人士持有。</p>
</div><h2>Eli Lilly and Company Company Profile</h2>
<div class="lb-trans"><h2>礼来公司公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供用于糖尿病的 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素 lispro、胰岛素 lispro 原料、胰岛素 lispro 混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500；用于 2 型糖尿病的 Jardiance、Mounjaro 和 Trulicity；以及用于肥胖症的 Zepbound。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>3 Dividend Stocks Raising Payouts—and Backing It Up With Results</li>
<li>The Most Important Warren Buffett Stock for Investors: His Own</li>
<li>3 Stocks With Monopoly Power—and Minimal Competition</li>
<li>Growth Investing: Should You Adopt This Investing Strategy in 2022?</li>
<li>Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>如何投资蓝筹股</li>
<li>3 只提高分红的股票——并以业绩支持这一点</li>
<li>投资者最重要的沃伦·巴菲特股票：他自己的股票</li>
<li>3 只拥有垄断权力且竞争极少的股票</li>
<li>成长投资：你应该在 2022 年采用这种投资策略吗？</li>
<li>火箭实验室发布第二季度业绩：牛市论点仍然成立吗？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding LLY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly and Company (NYSE:LLY - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 LLY 感兴趣的对冲基金持有什么吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Maia Wealth LLC 购入了礼来公司（NYSE:LLY）的 565 股股票